SELLAS Life Sciences Group, Inc. Increase (Decrease) in Restricted Cash
SELLAS Life Sciences Group, Inc. (SLS) reported Increase (Decrease) in Restricted Cash of $25.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-04-13
- SELLAS Life Sciences Group, Inc. increase (decrease) in restricted cash for the quarter ending 2017-06-30 was $7.00K.
- SELLAS Life Sciences Group, Inc. increase (decrease) in restricted cash for the quarter ending 2017-03-31 was $18.00K.
- SELLAS Life Sciences Group, Inc. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $85.00K.
- SELLAS Life Sciences Group, Inc. increase (decrease) in restricted cash for the quarter ending 2015-12-31 was $0.00.
- SELLAS Life Sciences Group, Inc. increase (decrease) in restricted cash for fiscal 2016 was $85.00K, a 57.71% decline from fiscal 2015.
- SELLAS Life Sciences Group, Inc. increase (decrease) in restricted cash for fiscal 2015 was $201.00K.
- SELLAS Life Sciences Group, Inc. increase (decrease) in restricted cash for fiscal 2013 was $99.00K.
- SELLAS Life Sciences Group, Inc. increase (decrease) in restricted cash for fiscal 2011 was $101.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 3 month as first filed | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month | Increase (Decrease) in Restricted Cash 12 month as first filed | Increase (Decrease) in Restricted Cash 108 month | Increase (Decrease) in Restricted Cash 111 month | Increase (Decrease) in Restricted Cash 114 month | Increase (Decrease) in Restricted Cash 117 month | Increase (Decrease) in Restricted Cash 120 month | Increase (Decrease) in Restricted Cash 123 month | Increase (Decrease) in Restricted Cash 126 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $25.00K 10-Q · filed 2017-08-14 | $110.00K derived: sum of 3 quarters · filed 2018-04-13 | ||||||||||
| 2017-03-31 | $18.00K 10-Q · filed 2017-05-10 | $103.00K derived: sum of 2 quarters · filed 2018-04-13 | |||||||||||
| 2016-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-13 | $85.00K 10-K · filed 2018-04-13 | $0.00 10-K · filed 2017-03-15 | ||||||||||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-09 | ||||||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $201.00K 10-K · filed 2017-03-15 | |||||||||||
| 2015-09-30 | $201.00K 10-Q · filed 2015-11-09 | ||||||||||||
| 2014-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2015-12-04 | $0.00 derived: sum of 2 quarters · filed 2015-12-04 | -$201.00K derived: sum of 3 quarters · filed 2015-12-04 | $0.00 8-K · filed 2015-12-04 | |||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$201.00K derived: sum of 2 quarters · filed 2014-11-05 | $0.00 10-Q · filed 2014-11-05 | $100.00K derived: sum of 4 quarters · filed 2016-11-09 | |||||||||
| 2014-06-30 | -$201.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $100.00K derived: sum of 3 quarters · filed 2016-11-09 | $98.00K derived: sum of 4 quarters · filed 2016-11-09 | |||||||||
| 2014-03-31 | $201.00K 10-Q · filed 2016-11-09 | $0.00 10-Q · filed 2014-05-06 | $301.00K derived: sum of 2 quarters · filed 2016-11-09 | $299.00K derived: sum of 3 quarters · filed 2016-11-09 | $299.00K derived: sum of 4 quarters · filed 2016-11-09 | ||||||||
| 2013-12-31 | $100.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-04-15 | $98.00K derived: sum of 2 quarters · filed 2016-04-15 | $98.00K derived: sum of 3 quarters · filed 2016-04-15 | $99.00K 10-K/A · filed 2016-04-15 | |||||||||
| 2013-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$2.00K derived: sum of 2 quarters · filed 2014-11-05 | -$1.00K 10-Q · filed 2014-11-05 | -$1.00K derived: sum of 4 quarters · filed 2014-11-05 | |||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $1.00K 10-Q · filed 2014-08-11 | $1.00K derived: sum of 3 quarters · filed 2014-08-11 | $1.00K derived: sum of 4 quarters · filed 2014-08-11 | $102.00K 10-Q · filed 2013-08-09 | ||||||||
| 2013-03-31 | $1.00K 10-Q · filed 2014-05-06 | $1.00K derived: sum of 2 quarters · filed 2014-05-06 | $1.00K derived: sum of 3 quarters · filed 2014-05-06 | $1.00K derived: sum of 4 quarters · filed 2014-05-06 | $102.00K 10-Q · filed 2013-05-09 | ||||||||
| 2012-12-31 | $0.00 derived: 10-K 120 month − 10-Q 117 month · filed 2013-03-12 | $0.00 derived: sum of 2 quarters · filed 2013-03-12 | $0.00 derived: sum of 3 quarters · filed 2013-03-12 | $0.00 derived: sum of 4 quarters · filed 2013-03-12 | $101.00K 10-K · filed 2013-03-12 | ||||||||
| 2012-09-30 | $0.00 derived: 10-Q 117 month − 10-Q 114 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $0.00 derived: sum of 3 quarters · filed 2012-11-13 | $101.00K 10-Q · filed 2012-11-13 | |||||||||
| 2012-06-30 | $0.00 derived: 10-Q 114 month − 10-Q 111 month · filed 2012-08-14 | $0.00 derived: sum of 2 quarters · filed 2012-08-14 | $101.00K 10-Q · filed 2012-08-14 | ||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 111 month − 10-K 108 month · filed 2012-05-14 | $101.00K 10-Q · filed 2012-05-14 | |||||||||||
| 2011-12-31 | $101.00K 10-K · filed 2014-03-17 | $101.00K 10-K · filed 2012-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |